Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.71 |
| ▸ | MAPT | P10636 | 2/20 | 0.71 |
| ▸ | MEN1 | O00255 | 2/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.71 |
| ▸ | LMNA | P02545 | 1/20 | 0.71 |
| ▸ | MPO | P05164 | 1/20 | 0.71 |
| ▸ | TSHR | P16473 | 1/20 | 0.71 |
| ▸ | BLM | P54132 | 1/20 | 0.71 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.71 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.71 |
| ▸ | TACR1 | P25103 | 2/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | APAF1 | O14727 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | SCN9A | Q15858 | 3/20 | 0.55 |
| ▸ | FAAH | O00519 | 1/20 | 0.55 |
| ▸ | HTR2A | P28223 | 2/20 | 0.54 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7775133 | 1.00 | KDM4E (0.71) | KDM4EMAPTMEN1KMT2ALMNA | |
| SCHEMBL27582874 | 0.90 | MEN1 (0.61) | KDM4EMAPTMEN1KMT2ALMNA | |
| SCHEMBL29233343 | 0.90 | MAPT (0.61) | KDM4EMAPTMEN1KMT2ALMNA | |
| SCHEMBL6032937 | 0.90 | KMT2A (0.71) | KDM4EMAPTMEN1KMT2ALMNA | |
| SCHEMBL597229 | 0.90 | KMT2A (0.71) | KDM4EMAPTMEN1KMT2ALMNA | |
| SCHEMBL1239230 | 0.89 | MEN1 (0.59) | KDM4EMAPTMEN1KMT2ALMNA | |
| Phenylalanine SCHEMBL10381280 | 0.89 | KMT2A (0.70) | KDM4EMAPTMEN1KMT2ALMNA | |
| Tryptophan SCHEMBL28205631 | 0.88 | KMT2A (0.65) | KDM4EMAPTMEN1KMT2ALMNA | |
| SCHEMBL6535365 | 0.88 | MEN1 (0.58) | KDM4EMAPTMEN1KMT2ALMNA | |
| SCHEMBL6535879 | 0.88 | MEN1 (0.58) | KDM4EMAPTMEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11845808-B2 | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases | JANSSEN BIOTECH, INC. (US) | 2023-12-19 | — | — | US | claimed |
| EP-1497452-B1 | METHODS FOR MEASURING ENZYME ACTIVITY | GE HEALTHCARE UK LTD (GB) | 2011-03-02 | — | — | EP | claimed |
| CN-112708589-B | Genetically engineered bacterium, construction method thereof and application thereof in fermentation production of 5-hydroxytryptophan | 南京工业大学 | 2023-12-22 | — | — | CN | disclosed |
| CN-116751696-A | Yarrowia lipolytica engineering bacterium for biosynthesis of 5-hydroxy beta-indolylalanine, construction and application thereof | 河北维达康生物科技有限公司 | 2023-09-15 | — | — | CN | disclosed |
| US-20210379052-A1 | QUINOLINE DERIVATIVE HAVING INDOLEAMINE-2,3-DIOXYGENASE INHIBITORY ACTIVITY | SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD. (CN) | 2021-12-09 | — | — | US | disclosed |
| EP-3858813-A1 | QUINOLONE DERIVATIVE HAVING INDOLEAMINE-2,3-DIOXYGENASE INHIBITED ACTIVITY | Shenzhen Chipscreen Biosciences Co., Ltd. (CN) | 2021-08-04 | — | — | EP | disclosed |
| CN-108101978-B | The Tyr-Pro-Trp-Phe-NH2 analog and its synthetic method of the esterification modification of C- terminal aromatic and application | 哈尔滨工业大学 | 2018-12-11 | — | — | CN | disclosed |
| CN-108101978-A | The Tyr-Pro-Trp-Phe-NH2 analog and its synthetic method of the esterification modification of C- terminal aromatics and application | 哈尔滨工业大学 | 2018-06-01 | — | — | CN | disclosed |
| CN-104704129-A | Mutations associated with resistance to Bruton's tyrosine kinase (BTK) inhibitors | PHARMACYCLICS INC | 2015-06-10 | — | — | CN | disclosed |
| CN-101351561-A | A method of measuring enzymatic activity of adsorbed allergenic enzyme | ALK ABELLO AS (DK) | 2009-01-21 | — | — | CN | disclosed |
| EP-1135398-A1 | CYANOPHOSPHONAMIDES AND METHOD FOR PREPARATION | Monsanto Technology LLC (US) | 2001-09-26 | — | — | EP | disclosed |
| US-6218563-B1 | Cyanophosphonamides and method for preparation | MONSANTO COMPANY | 2001-04-17 | — | — | US | disclosed |
| WO-2000032611-A1 | CYANOPHOSPHONAMIDES AND METHOD FOR PREPARATION | MONSANTO TECHNOLOGY LLC (US) | 2000-06-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210379052-A1 | QUINOLINE DERIVATIVE HAVING INDOLEAMINE-2,3-DIOXYGENASE INHIBITORY ACTIVITY | IDO1, IDO2, INMT | KDM4E 106/4885MAPT 3101/4885MEN1 3118/4885 |
| US-11845808-B2 | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases | IL23R, IL1RN, VIP | KDM4E 4705/4885MAPT 2759/4885MEN1 3503/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.